Weik Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-1,885
Closed -$276K 123
2019
Q1
$276K Sell
1,885
-50
-3% -$7.25K 0.13% 108
2018
Q4
$259K Sell
1,935
-325
-14% -$53.3K 0.14% 105
2018
Q3
$430K Buy
+2,260
New +$415K 0.21% 88
2017
Q4
Sell
-1,205
Closed -$247K 125
2017
Q3
$247K Buy
1,205
+350
+41% +$81.4K 0.12% 112
2017
Q2
$208K Hold
855
0.11% 112
2017
Q1
$204K Buy
+855
New +$199K 0.11% 111
2016
Q4
Sell
-1,175
Closed -$271K 116
2016
Q3
$271K Buy
1,175
+75
+7% +$18.3K 0.16% 98
2016
Q2
$254K Buy
+1,100
New +$254K 0.15% 98

Other funds holding AGN

Weik Capital Management's AGN Position: Q2 2019 in Review

Weik Capital Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 1,885 shares — an estimated $276K sold.

Weik Capital Management first reported a position in AGN in Q2 2016 and held it in 8 quarters. The position peaked at $430K in Q3 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Weik Capital Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Weik Capital Management sold 1,885 Allergan plc shares in Q2 2019, an estimated $276K.
  • Weik Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 8 quarters.
  • Weik Capital Management's Allergan plc position peaked at $430K in Q3 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Weik Capital Management's 13F filing for Q2 2019, filed 9 Aug 2019.